A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis
Phase of Trial: Phase III
Latest Information Update: 20 Aug 2015
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Roche
- 14 Oct 2014 Status changed from active, no longer recruiting to completed, as reported by the ClinicalTrials.gov record.
- 31 Mar 2014 Planned End Date changed from 1 Jan 2014 to 1 Jun 2014 as as reported by ClinicalTrials.gov.
- 23 May 2013 Planned end date changed from 1 Apr 2014 to 1 Jan 2014 as reported by ClinicalTrials.gov.